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 Abstract 
Maternal gut microbiota is thought to be one of the important factors in the 
developmental origins of health and disease (DOHaD) concept, but the effects of 
maternal gut microbiota on foetal growth are not well known. In this study, the 
association between maternal gut microbiota and foetal growth was investigated. 
Maternal and newborn information, as well as stool samples at the third trimester of 
pregnancy, were obtained from 51 mother-newborn pairs from the Chiba study of 
Mother and Child Health (C-MACH). Gut microbiota was analysed by 16S rRNA 
sequencing of stool samples and short-chain fatty acids (SCFAs) in stool were analysed 
by gas chromatography-tandem mass spectrometry. After adjustment for covariates, it 
was found that maternal gut microbial diversity had a positive association with newborn 
head circumference in males (Chao 1: adjusted r = 0.515, p = 0.029). Genus 
Parabacteroides and genus Eggerthella showed negative associations with newborn 
head circumference and weight respectively in males (genus Parabacteroides: adjusted 
r = -0.598, p = 0.009, genus Eggerthella: adjusted r = -0.481, p = 0.043). On the other 
hand, genus Streptococcus showed a negative association with newborn height in 
females (adjusted r = -0.413, p = 0.040). In addition, hexanoate was involved in the 
association between maternal gut microbiota and newborn anthropometrics in the 
univariate analysis, but not in the multivariate analysis. These data suggest that maternal 
gut microbiota has sex-specific effects on foetal growth. Maternal gut microbiota is an 
important factor for optimal intrauterine growth.  
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 Introduction 
Known as the developmental origins of health and disease (DOHaD) concept, exposure 
to environmental factors during the foetal period to early childhood affects the risk of 
noncommunicable diseases (NCDs) in adulthood.1-3 In other words, according to this 
concept, foetal growth is a good predictor of the risk of NCDs in adulthood.3 A wide 
range of maternal factors, including body composition, nutrition, stress, and smoking, 
have been reported to affect foetal growth and the subsequent risk of NCDs.4, 5 
  Recently, in addition to these factors, there has been great interest in the role of 
maternal gut microbiota in the DOHaD concept. Disruption of the maternal gut 
microbiota balance (dysbiosis) alters the child’s gut microbiota and immunity through 
vertical transmission from leaky gut and/or placenta, delivery, or breastfeeding, and this 
dysbiosis affects the risk of NCDs in adulthood.6, 7 Thus, the maternal gut microbiota is 
thought to be an important factor contributing to the child’s health in later life, but 
studies investigating the effects of maternal gut microbiota on foetal growth are limited.  
Few studies have reported the associations between maternal gut microbiota and 
foetal growth.8, 9 Santacruz et al. reported that some genera of maternal gut microbiota 
were associated with increased newborn weight. Priyadarshini et al. reported that 
maternal serum levels of short-chain fatty acids (SCFAs), partly originated from 
microbiota fermentation in the gut, were associated with newborn height and weight. 
These studies suggest the importance of further research on the effects of maternal gut 
microbiota on foetal growth.  
  Additionally, there is emerging indirect evidence on the importance of sex 
dimorphism on the association between maternal gut microbiota and foetal growth. It 
has been found that prenatal exposures that are linked to the composition of the 
maternal gut microbiota, such as maternal smoking10, 11 and antibiotic use,12 have 
sex-specific effects on foetal growth. However, to our knowledge, there is no study that 
has investigated the direct association between maternal gut microbiota and foetal 
 growth with respect to sex dimorphism. It was hypothesized that the maternal 
microbiota has sex-specific effects on foetal growth. Therefore, this study aimed to 
clarify the associations between maternal gut microbiota and foetal growth in both 
males and females.  
 
Methods 
Study subjects 
The Chiba study of Mother and Child Health (C-MACH) is an ongoing prospective 
birth cohort study comprising approximately 400 mother-child pairs. The study 
investigates the association of genetic and environmental factors with child health using 
multi-omics analysis.13 Of the participants in C-MACH, 58 women consented to 
provide their stool samples. Of those, 6 were excluded from the analysis due to missing 
maternal or newborn information and 1 due to maternal antibiotic use. Therefore, a total 
of 51 mother-newborn pairs were included in this analysis.  
  This study was conducted according to the Declaration of Helsinki and the Ethical 
Guidelines for Medical and Health Research Involving Human Subjects by the Japanese 
Ministry of Health, Labor and Welfare. The study protocol was approved by the 
Biomedical Research Ethic Committee of the Graduate School of Medicine, Chiba 
University. Prior to the start of the study, all participants provided written informed 
consent. 
 
Maternal and newborn information 
Maternal information including age, parity, anthropometrics, and antibiotic use during 
pregnancy was obtained from self-administered questionnaires at the first trimester 
(around 12 weeks) or third trimester (around 32 weeks). The other maternal and 
newborn information, including delivery mode, gestational age, newborn gender, and 
anthropometrics, were obtained from medical records. Gestational weight gain was 
 calculated by subtracting pre-pregnancy weight from weight at the third trimester. To 
adjust for variations in parity, gestational age, and newborn gender, newborn 
anthropometrics were converted to standard deviation scores (SDSs) based on Japanese 
growth reference curves.14 
 
Analysis of gut microbiota and SCFAs in stool 
Sample collection and DNA extraction 
Stool samples were collected at the third trimester of pregnancy for analysis of the gut 
microbiota and SCFAs. They were frozen at −18°C following collection at home, and 
transferred to the Chiba University Center for Preventive Medical Sciences (CPMS) 
Biobank and stored at −80°C until ready for use. 
  Microbial DNA extraction was performed according to previous studies with minor 
modifications.15 Stool samples with a mass of 5.0 grams were suspended in 30.0 mL of 
methanol, and then filtered using Steriflip filters (Merck, Darmstadt, Germany) with a 
pore size of 100 μm. The filtered suspension was centrifuged and separated into the 
supernatant and pellet. The supernatant and the pellet in methanol were stored at -80°C 
until metabolomic analysis and DNA extraction, respectively. The 50.0 mg pellet was 
re-suspended in 450 μl of 10x Tris-EDTA buffer and incubated with 15 mg/ml lysozyme 
(FUJIFILM Wako Pure Chemical Corporation, Osaka, Japan) at 37°C for 1 hour. 
Purified achromopeptidase (FUJIFILM Wako Pure Chemical Corporation) at a final 
concentration of 2000 units/ml was added and then incubated at 37°C for 30 minutes. 
The suspension was added to 1% (wt/vol) sodium dodecyl sulphate and 1 mg/ml 
proteinase K (Merck) and incubated at 55°C for 1 hour. The microbial DNA was 
purified using a phenol/chloroform/isoamyl alcohol (25:24:1) solution (Nacalai Tesque, 
Kyoto, Japan). The DNA was precipitated by adding ethanol and sodium acetate. RNase 
(NIPPON GENE, Tokyo, Japan) treatment and polyethylene glycol precipitation was 
performed. The DNA was cleaned using the Wizard SV Gel and PCR Clean-Up System 
 (Promega, WI, USA).  
16S rRNA sequencing V1-2 region 
The V1-2 variable region (27Fmod - 338R15) was sequenced on an Illumina Miseq 
(Illumina, San Diego, CA, USA). The 16S rRNA V1–V2 amplicon was amplified using 
KAPA HiFi Hot Start Ready Mix (2x) (TaKaRa Bio, Shiga, Japan). Two Universal 
bacterial 16S rRNA gene primers were used: (1) the forward primer 
(TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGAGRGTTTGATYMTGGCTC
AG) and (2) reverse primer 
(GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGATTACCGCGGCTGCTGG). 
The first reaction mixture contained 6 pmol of each primer, 12.5 ng of microbial DNA, 
12.5 μl of KAPA HiFi Hot Start Ready Mix (2x), and sterilized water to reach a final 
volume of 30 μl. PCR conditions were as follows: 95°C for 2 minutes, 20 cycles of 
95°C for 30 seconds, 55°C for 30 seconds, and 72°C for 1 minute, followed by 72°C for 
3 minutes. The PCR product was purified through the use of AMPure XP (Beckman 
Coulter, Brea, CA, USA) and confirmed using electrophoresis in 3% (w/v) agarose gels. 
  Dual indexes and Illumina sequencing adapters were attached to PCR products using 
the Nextera XT Index Kit (Illumina). After purification of the amplicon using AMPure 
XP beads, these samples were quantified using a Quant-iT PicoGreen ds DNA Assay 
Kit (Life Technologies Japan, Tokyo, Japan). 
  Mixed samples were prepared by pooling approximately equal amounts of PCR 
amplicons from each sample. The pooled library was analysed with an Agilent High 
Sensitivity DNA Kit on an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, 
CA, USA). Real-time PCR for quantification of the pooled library was performed using 
a KAPA Library Quantification Kit (Kapa Biosystems, Boston, MA, USA) for Illumina 
following the manufacturer’s protocols. Based on the quantifications, the sample library 
was denatured and diluted. A sample library with 20% denatured PhiX spike-in 
(SeqMatic LLC, Fremont, CA, USA) was sequenced on the Miseq using a 500 cycle kit. 
   Taxonomic assignments and estimation of relative abundance of sequencing data 
were performed using the analysis pipeline of the QIIME software package.16 Chimera 
checking was performed using UCHIME.17 An operational taxonomic unit (OTU) was 
defined at 97% similarity. The OTU was assigned a taxonomy based on a comparison 
with the Greengenes database using RDPclassifier.18, 19 The proportions of identified 
taxa in each sample were summarized and the amount of bacterial diversity was 
calculated. The Shannon index, a measurement of within-sample (alpha-diversity) 
community diversity, as well as Chao 1 (estimates richness), and observed OTUs were 
used to evaluate the alpha-diversity. 
Measurement of SCFAs 
Extraction and measurement of SCFAs was performed according to previous studies 
with some modifications.20 A methanol extract with a volume of 25.0 μl was added to 
5.0 μl of Milli-Q water containing internal standards (2.2 mM [1,2-13C2] acetate, 2.2 
mM [2H7] butyrate and 2.2 mM crotonate), and then, centrifugally concentrated at 40°C 
and reconstituted with 100.0 μl of Milli-Q water. Next, 50.0 μl of hydrochloric acid and 
200.0 μl of diethyl ether were added and the solution was mixed well. After 
centrifugation at 3000 g for 10 minutes, 80.0 μl of the organic layer was transferred to a 
glass vial and 16.0 μl of N-tert-butyldimethylsilyl-N-trifluoroacetamide (MTBSTFA) 
(Sigma-Aldrich, St. Louis, MO, USA) was added to derivatize the samples. The vials 
were incubated at 80°C for 20 minutes and were allowed to stand for 48 hours before 
injection. The analysis was performed using gas chromatography-tandem mass 
spectrometry (GC/MS/MS) platforms on a Shimadzu GCMS-TQ8030 triple quadrupole 
mass spectrometer (Shimadzu, Kyoto, Japan) with a capillary column (BPX5) (SGE 
Analytical Science Pty. Ltd, Melbourne, Australia). The GC oven was programmed as 
follows: 60°C held for 3 minutes, increased to 130°C (at a rate of 8°C/min), increased to 
330°C (at a rate of 30°C/min), and held at 330°C for 3 minutes. The detector and 
injector temperatures were 230°C and 250°C, respectively. GC was performed in 
 constant linear velocity mode set to 40 cm/sec. Injection volume was set at 1.0 μl with a 
split ratio of 1:30. 
 
Statistical analysis 
Baseline characteristics are presented as median (interquartile range; IQR) or percentage 
of subjects. Mann-Whitney U tests, Chi square tests or Fisher’s exact tests were 
performed to compare newborn characteristics between males and females.  
  Maternal microbial diversity, the proportion of microbiota at the phylum and genus 
levels, and concentrations of SCFAs in stool are presented as median (IQR). Only the 
microbiota or SCFAs detected in more than half of the subjects were used for analysis. 
  Spearman’s rank correlation coefficient analysis was performed to assess the 
association of maternal gut microbial diversity or composition with newborn 
anthropometrics. Then, Spearman’s partial correlation coefficient analysis was 
performed to adjust the basic models for covariates including maternal height, 
pre-pregnancy body mass index (BMI), gestational weight gain, and delivery mode. The 
same analyses were performed to assess the association of maternal SCFAs in stool with 
newborn anthropometrics. In addition, Spearman’s rank correlation coefficient analysis 
was also performed to assess the association of maternal SCFAs in stool with the 
maternal gut microbiota related to newborn anthropometrics. 
  All statistical analyses were conducted using SPSS version 24 (IBM Corp., Armonk 
NY, USA) and R version 3.4.0 (R Core Team, 2017).21 Partial correlation coefficients 
were calculated using package “ppcor”.22 Statistical significance was defined by a p 
value <0.05. 
 
Results 
Maternal and newborn characteristics 
Characteristics of the mothers and newborns are presented in Table 1. The median 
 (IQR) maternal age, pre-pregnancy BMI, and gestational weight gain was 34 (5) years, 
20.3 (3.4) kg/m2, and 8.5 (5.1) kg, respectively. Of the 51 mothers, only 8% (n = 4) 
were overweight prior to pregnancy. Of the 51 newborns, 56.9% were females (n = 29), 
and the remaining 44.1% were males (n = 22). The median (IQR) newborn height, 
weight, and head circumference at birth was 49.5 (1.0) cm, 3054 (322) g, and 33.0 (1.5) 
cm, respectively. All newborn heights and weights were within the standard ranges. 
Only 1 male newborn’s head circumference deviated from the range of ± 2.0 standard 
deviations (2.21), while all others were within the standard ranges. 
 
Association between maternal gut microbial diversity and newborn anthropometrics 
Maternal gut microbial diversity is presented in Table 2. To assess the association of 
maternal gut microbial diversity with newborn anthropometrics, Spearman’s rank 
correlation coefficient analysis was performed. There were significant positive 
correlations between all alpha-diversity indexes of maternal gut microbiota and 
newborn head circumference SDS in males (observed OTUs: r = 0.526, p = 0.012, Chao 
1: r = 0.591, p = 0.004, Shannon index: r = 0.477, p = 0.025; Table 3); this was not 
found in females. Newborn height SDS and weight SDS were not significantly 
correlated with maternal gut microbial diversity, regardless of gender. 
  To evaluate the association of maternal gut microbial diversity with newborn head 
circumference in detail, adjusted correlation coefficient was calculated with maternal 
factors as covariates (Table 4). Chao 1 and newborn head circumference in males were 
significantly positively correlated, even after adjustment for the covariates (adjusted r = 
0.515, p = 0.029).  
 
Association between maternal gut microbiota composition and newborn 
anthropometrics 
The proportions of maternal gut microbiota at the phylum and genus levels are 
 presented in Table 5. To assess the association of maternal gut microbiota composition 
with newborn anthropometrics, Spearman’s rank correlation coefficient analysis was 
performed. There were no significant correlations between the phyla of the maternal gut 
microbiota and newborn anthropometrics, regardless of gender (Table 6). In contrast, 
there were significant correlations between three genera of maternal gut microbiota and 
newborn weight SDS in males, as well as between seven genera of maternal gut 
microbiota and newborn head circumference SDS (Table 7). Only one genus of 
maternal gut microbiota was significantly correlated with newborn height SDS and 
weight SDS in females. 
  To evaluate the association of these genera of maternal gut microbiota with newborn 
anthropometrics in detail, adjusted correlation coefficient was calculated with maternal 
factors as covariates (Table 7). Genus Parabacteroides and genus Eggerthella showed 
significant negative correlations with newborn head circumference SDS and weight 
SDS, respectively, in males, even after adjustment for the covariates (genus 
Parabacteroides: adjusted r = -0.598, p = 0.009, genus Eggerthella: adjusted r = -0.481, 
p = 0.043). On the other hand, genus Streptococcus showed a significant negative 
correlation with newborn height SDS in females, even after adjustment for the 
covariates (adjusted r = -0.413, p = 0.040).  
 
Association between maternal SCFAs in stool and newborn anthropometrics 
The concentrations of SCFAs in maternal stool are presented in Table 8. As the 
mechanism by which gut microbiota affects the host’s physiology could be, in part, 
mediated by SCFAs, the association of SCFAs in stool with newborn anthropometrics 
was assessed. There was a significant positive correlation between hexanoate and 
newborn head circumference SDS in males, as well as newborn height SDS in females 
(Table 9).  
  To evaluate the association of hexanoate with newborn anthropometrics in detail, 
 adjusted correlation coefficient analysis was calculated with maternal factors as 
covariates (Table 10). There were no significant associations between hexanoate and 
newborn anthropometrics after adjustment for the covariates. 
  In addition, to evaluate the involvement of SCFAs in the associations between 
maternal gut microbiota and newborn anthropometrics, we attempted to explore the 
correlations between the maternal SCFAs in stool and the maternal gut microbiota 
related to newborn anthropometrics (Figure 1). There were stronger correlations 
between hexanoate and the maternal gut microbiota, when compared to other major 
SCFAs including acetate, propionate, and butyrate.  
 
Discussion 
In the present study, the associations between maternal gut microbiota and foetal growth 
in both males and females were investigated. It was found that lower maternal gut 
microbial diversity as well as higher proportions of genera Parabacteroides and 
Eggerthella were associated with smaller newborn head circumference or weight in 
males. On the other hand, a higher proportion of genus Streptococcus was associated 
with smaller newborn height in females. Moreover, SCFAs in stool, especially 
hexanoate, were involved in the association between maternal gut microbiota and 
newborn anthropometrics in the univariate analysis, but not in the multivariate analysis. 
These findings suggest that maternal gut microbiota possibly have sex-specific effects 
on foetal growth. To our knowledge, this is the first study to show a sex-specific 
relationship between maternal gut microbiota and newborn anthropometrics. 
  The findings observed predominately in males in the present study are similar to 
those of a previous study that showed male-specific effects of prenatal exposures, which 
were linked to the composition of the gut microbiota.12 Indeed, maternal use of 
antibiotics during pregnancy was associated with lower birth weight in males but not in 
females. While the previous study provided indirect evidence for the male-specific 
 effect of the gut microbiota, the results of the present study provide direct evidence of a 
male dominant association between maternal gut microbiota and foetal growth. 
Although the mechanism underlying the sex-specific effects on foetal growth remains 
unclear, maternal exposure during pregnancy could be transmitted from the maternal to 
the foetal compartment via the placenta in a sex-specific manner and subsequently 
affect foetal tissue development.23 
  Unlike in previous studies,12 we found that maternal gut microbiota (genus 
Streptococcus) was associated with newborn anthropometrics in females as well. This 
difference may be due to the different distribution of the microbiota in mothers with 
male and female foetuses. Although the cause was unclear, all mothers with a male 
foetus had a proportion of genus Streptococcus ≤5%, while approximately a quarter of 
mothers with a female foetus had higher proportions of Streptococcus than the mothers 
with a male foetus (data not shown). Streptococci are pathobionts in both mothers and 
newborns, and the vertical transmission from mother to foetus has been shown to cause 
poor outcomes in newborns.24, 25 The high rates of Streptococcus in some mothers with 
a female foetus in our cohort might have a large impact on the female-specific results. 
In other words, when these mothers were excluded, there was no significant association 
between maternal Streptococcus and newborn height in females (data not shown).  
  Many studies have demonstrated that smaller birth size is associated with worse 
outcomes in later life. For instance, several studies have reported that smaller birth size, 
especially head circumference, is strongly associated with increased risk of death from 
coronary heart disease in adulthood.26, 27 In addition, a recent study showed that small 
head circumference at birth was associated with early adiposity rebound, which is a 
predictor of obesity and type 2 diabetes, and hence coronary heart disease in later life.28 
Moreover, smaller birth size has been reported to be associated with poor intellectual 
ability in childhood29 or adulthood.30 Together with the present results, further studies 
investigating adiposity rebound or intellectual ability in childhood are needed to clarify 
 the effects of maternal gut microbiota and small birth size on health and disease in later 
life.  
  The alterations of gut microbiota observed in this study could be associated with the 
host’s systemic inflammatory condition. Indeed, lower maternal gut microbial diversity 
increases translocation of bacteria-derived products across the intestinal mucosa, which 
could contribute to systemic and placental inflammation.7, 31 Genus Parabacteroides 
was reported to be present at a higher abundance in non-alcoholic steatohepatitis 
(NASH) patients, whose gut dysbiosis induced pro-inflammatory activity and immune 
imbalances through hepatotoxic effects.32 Genus Eggerthella has been known as a cause 
of severe bacteraemia from a gastrointestinal tract source.33, 34 Gastrointestinal 
colonization by genus Streptococcus is a risk factor for vaginal colonization, which 
induces inflammatory cytokine release in placental tissues or the amniotic fluid.25 Based 
on these studies, it could be hypothesized that such systemic inflammatory conditions 
caused by maternal gut microbiota might contribute to foetal growth. Many studies have 
reported that prenatal inflammation contributes to foetal growth restriction and 
neurodevelopmental impairments through pro-inflammatory cytokines and 
chemokines.35, 36 Additionally, such prenatal inflammation is reportedly of greater 
magnitude,37, 38 and produces a larger effect39 in the male foetus. In other words, this 
hypothesis could explain the male dominant effects of maternal gut microbiota on foetal 
growth. It is important to analyse these various cytokines and chemokines in maternal 
stool and serum samples, as well as cord serum samples, to clarify the mechanism by 
which maternal gut microbiota affects newborn anthropometrics in a sex-specific 
manner. 
  In the present study, it was not clear whether the SCFAs contributed to the association 
between maternal microbiota and foetal growth. Hexanoate was involved in the 
association between maternal gut microbiota and newborn anthropometrics in the 
univariate analysis, but not in the multivariate analysis. However, decreased hexanoate 
 has been reported to indicate gut dysbiosis and subsequent gut systemic inflammation in 
patients with metabolic syndrome40 or psoriatic arthritis.41 Assuming that the decreased 
hexanoate and altered microbiota mentioned above are related to the host systemic 
inflammatory condition, the sample size might have been insufficient to show a 
significant association between maternal hexanoate in stool and foetal anthropometrics. 
  This study had several limitations. First, the sample size was relatively small; 
therefore, p values could not be adjusted sufficiently to control for multiple testing. 
Studies with a large number of subjects are necessary to perform more robust statistical 
analyses and further validate the findings presented here. Furthermore, all the study 
subjects were Japanese, and therefore, some of the taxonomic findings may not 
necessarily conform to other ethnic or racial groups, or individuals from other 
geographic regions. To generalize these findings, the association between maternal gut 
microbiota and foetal growth in other ethnic or regional groups would need to be 
investigated.   
  In conclusion, it was found that lower maternal gut microbial diversity and higher 
proportions of genera Parabacteroides and Eggerthella were associated with smaller 
newborn anthropometrics in males, while a higher proportion of genus Streptococcus 
was associated with smaller newborn anthropometrics in females. These findings 
suggest that maternal gut microbiota is an important factor for optimal intrauterine 
growth. Further studies are needed to confirm the mechanism by which maternal gut 
microbiota affects foetal growth in a sex-specific manner, and its effects on health and 
disease in later life. 
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 Table 1. Maternal and newborn characteristics 
Variables 
Total Males Females 
p-value 
(n = 51) (n = 22) (n = 29) 
Maternal         
Age (year) 34 (5) 34 (6) 34 (6) 0.491 
Height (cm) 159.0 (8.0) 157.0 (10.2) 160.0 (6.3) 0.614 
Pre-pregnancy weight (kg) 52.0 (7.9) 52.5 (9.4) 51.0 (7.5) 0.932 
Pre-pregnancy BMI (kg/m2) 20.3 (3.4) 20.2 (3.9) 20.3 (3.3) 0.746 
Weight at the third trimester (kg) 60.2 (10.6) 60.4 (12.2) 59.6 (9.7) 0.739 
BMI at the third trimester (kg/m2) 24.1 (3.5) 24.4 (4.2) 23.0 (3.8) 0.323 
Gestational weight gain (kg) 8.5 (5.1) 8.5 (4.2) 7.2 (5.9) 0.254 
Delivery mode (% vaginal) 86.3 81.8 89.7 0.447 
Parity (% first) 29.4 40.9 20.7 0.117 
Newborn         
Gender (% females) 56.9 - -   
Gestational age (weeks) 39 (2) 39 (2) 39 (2) 0.849 
Height (cm) 49.5 (1.0) 49.8 (1.4) 49.5 (1.0) 0.614 
Weight (g) 3054 (322) 3040 (481) 3062 (247) 0.739 
Head circumference (cm) 33.0 (1.5) 33.5 (1.1) 33.0 (2.0) 0.412 
Height SDS 0.12 (0.88) 0.22 (0.80) 0.12 (0.88) 0.493 
Weight SDS -0.13 (0.97) -0.20 (0.91) 0.05 (0.99) 0.077 
Head circumference SDS -0.14 (0.89) 0.04 (0.79) -0.21 (1.23) 0.351 
Values are presented as median (interquartile range) or percentage of subjects.  
Mann-Whitney U tests, Chi square tests or Fisher’s exact tests were performed to 
compare newborn characteristics between males and females. 
BMI: body mass index 
SDS: standard deviation score 
 
 Table 2. Maternal gut microbial diversity 
Variables 
Total 
(n=51) 
Males 
(n=22) 
Females 
(n=29) 
Observed OTUs 447 (115) 460.5 (145.25) 431 (134.5) 
Chao1 651 (192.1961) 694.6431 (248.1962) 622.6 (158.5299) 
Shannon 4.5565 (0.403) 4.5694 (0.3798) 4.5456 (0.4896) 
Values are presented as median (interquartile range). 
OTUs: operational taxonomic units 
  
 Table 3. Correlation between maternal gut microbial diversity and newborn 
anthropometrics 
Variables 
Height SDS Weight SDS Head circumference SDS 
r p value r p value r p value 
Males             
Observed OTUs -0.082  0.717  0.015  0.948  0.526  0.012  
Chao 1 0.070  0.757  0.127  0.573  0.591  0.004  
Shannon index -0.218  0.330  0.057  0.801  0.477  0.025  
Females             
Observed OTUs -0.020  0.917  -0.182  0.345  -0.217  0.258  
Chao 1 0.065  0.738  -0.155  0.422  -0.327  0.083  
Shannon index 0.129  0.506  -0.122  0.528  -0.237  0.217  
r Values indicate Spearman’s rank correlation coefficients. 
Significant p values (p < 0.05) are shown in bold. 
SDS: standard deviation score 
OTUs: operational taxonomic units 
  
 Table 4. Adjusted correlation between each alpha-diversity index of maternal 
microbiota and newborn head circumference in males 
Variables Adjusted r p value 
Observed OTUs 0.430 0.075 
Chao 1 0.515 0.029 
Shannon index 0.335 0.174 
Adjusted r values indicate Spearman’s partial correlation coefficients with covariates 
including maternal height, pre-pregnancy BMI, gestational weight gain, and delivery 
mode. 
Significant p value (p < 0.05) is shown in bold. 
OTUs: operational taxonomic units 
  
 Table 5. The proportions of maternal gut microbiota at the phylum and genus levels 
Variables 
Total 
(n=51) 
Males 
(n=22) 
Females 
(n=29) 
Phylum    
Actinobacteria 0.1362 (0.1349) 0.1446 (0.125) 0.1241 (0.1329) 
Bacteroidetes 0.1887 (0.1387) 0.1412 (0.1601) 0.2018 (0.1501) 
Firmicutes 0.6467 (0.1389) 0.6878 (0.1293) 0.6082 (0.0985) 
Proteobacteria 0.0083 (0.0117) 0.007 (0.0079) 0.0103 (0.0116) 
Genus    
Actinomyces 0.0006 (0.0006) 0.0007 (0.0006) 0.0005 (0.0007) 
Rothia 0.0001 (0.0003) 0.0001 (0.0002) 0.0001 (0.0004) 
Bifidobacterium 0.1082 (0.0996) 0.1123 (0.1078) 0.1082 (0.1261) 
Coriobacteriaceae unclassified 0.0003 (0.0014) 0.0003 (0.0021) 0.0002 (0.0013) 
Adlercreutzia 0.0002 (0.0012) 0.0003 (0.0012) 0.0002 (0.0012) 
Collinsella 0.0164 (0.0442) 0.0188 (0.0523) 0.013 (0.0384) 
Eggerthella 0.0008 (0.0023) 0.0005 (0.0026) 0.0011 (0.0022) 
Bacteroides 0.1178 (0.1391) 0.1085 (0.1322) 0.151 (0.1766) 
Parabacteroides 0.0071 (0.0117) 0.0067 (0.0077) 0.0074 (0.0163) 
Prevotella 0.0001 (0.0074) 0.0003 (0.0116) 0.0001 (0.0016) 
Rikenellaceae unclassified 0.0035 (0.0078) 0.0036 (0.0069) 0.0032 (0.0097) 
Alistipes 0.0001 (0.001) 0.0003 (0.0013) 0 (0.001) 
Barnesiellaceae unclassified 0.0007 (0.0035) 0.0006 (0.0034) 0.0007 (0.0038) 
Odoribacter 0.0007 (0.0012) 0.0006 (0.0006) 0.0008 (0.0014) 
Granulicatella 0.0001 (0.0002) 0.0001 (0.0002) 0.0001 (0.0004) 
Lactobacillus 0.0003 (0.0008) 0.0003 (0.0007) 0.0003 (0.0016) 
Lactococcus 0.0001 (0.0003) 0.0001 (0.0003) 0.0001 (0.0003) 
Streptococcus 0.016 (0.0292) 0.0119 (0.0164) 0.0185 (0.0451) 
Turicibacter 0.0001 (0.0006) 0.0003 (0.0006) 0.0001 (0.0006) 
Christensenellaceae unclassified 0.0002 (0.0009) 0.0004 (0.0012) 0 (0.0006) 
G 02d06 0.0001 (0.0005) 0 (0.0004) 0.0001 (0.0006) 
Clostridiaceae Clostridium 0.0032 (0.0061) 0.0026 (0.0065) 0.0042 (0.0063) 
SMB53 0.003 (0.0058) 0.0031 (0.0052) 0.0027 (0.007) 
Lachnospiraceae unclassified 0.0859 (0.0711) 0.0691 (0.0658) 0.0946 (0.0731) 
Anaerostipes 0.0026 (0.0066) 0.0031 (0.006) 0.0015 (0.0067) 
Blautia 0.1062 (0.0588) 0.1207 (0.0629) 0.0944 (0.0655) 
 Lachnospiraceae Clostridium 0.0004 (0.0009) 0.0004 (0.0008) 0.0004 (0.0009) 
Coprococcus 0.0211 (0.0256) 0.0231 (0.0213) 0.0197 (0.0306) 
Dorea 0.0232 (0.0194) 0.0236 (0.0181) 0.0232 (0.0202) 
Lachnobacterium 0.0004 (0.0012) 0.0007 (0.0016) 0.0002 (0.0011) 
Lachnospira 0.0059 (0.012) 0.0065 (0.0095) 0.0052 (0.0125) 
Roseburia 0.0075 (0.0211) 0.0137 (0.0301) 0.0065 (0.0151) 
Lachnospiraceae Ruminococcus 0.0281 (0.033) 0.0245 (0.0324) 0.0302 (0.0319) 
Ruminococcaceae unclassified 0.0241 (0.0369) 0.0241 (0.0623) 0.0252 (0.03) 
Butyricicoccus 0.003 (0.004) 0.0028 (0.0039) 0.003 (0.0042) 
Faecalibacterium 0.0353 (0.0669) 0.0286 (0.0446) 0.0499 (0.0861) 
Oscillospira 0.0147 (0.0172) 0.0174 (0.0239) 0.0113 (0.0164) 
Ruminococcus 0.0464 (0.1142) 0.0928 (0.1034) 0.0174 (0.1) 
Dialister 0.0005 (0.0053) 0.0016 (0.0116) 0.0003 (0.0009) 
Phascolarctobacterium 0.0028 (0.008) 0.0031 (0.0102) 0.0028 (0.0071) 
Veillonella 0.0002 (0.0022) 0.0001 (0.0008) 0.0006 (0.0065) 
Mogibacteriaceae unclassified 0.0018 (0.0036) 0.0025 (0.0039) 0.0016 (0.0034) 
Erysipelotrichaceae unclassified 0.0048 (0.0121) 0.0053 (0.0113) 0.0044 (0.0154) 
Erysipelotrichaceae Clostridium 0.0005 (0.0027) 0.0004 (0.0028) 0.0006 (0.0025) 
Coprobacillus 0.0004 (0.0015) 0.0006 (0.0036) 0.0004 (0.0014) 
Holdemania 0.0001 (0.0003) 0.0002 (0.0003) 0.0001 (0.0002) 
Eubacterium 0.0027 (0.0059) 0.0023 (0.0353) 0.0033 (0.005) 
cc 115 0.0002 (0.0013) 0.0003 (0.0012) 0.0001 (0.0018) 
Sutterella 0.0024 (0.0049) 0.0016 (0.0038) 0.0029 (0.0063) 
Bilophila 0.0009 (0.0021) 0.0007 (0.0016) 0.0012 (0.0021) 
Trabulsiella 0.0011 (0.005) 0.0006 (0.0013) 0.0021 (0.0051) 
unassigned 0.0076 (0.0133) 0.0084 (0.0197) 0.0066 (0.0113) 
Values are presented as median (interquartile range). 
  
 Table 6. Correlation between phylum of maternal microbiota and newborn 
anthropometrics 
Variables 
Height SDS Weight SDS Head circumference SDS 
r p value r p value r p value 
Males             
Actinobacteria -0.221  0.322  0.073  0.747  -0.072  0.749  
Bacteroidetes 0.037  0.869  0.112  0.619  -0.243  0.275  
Firmicutes 0.104  0.644  -0.212  0.344  0.295  0.183  
Proteobacteria -0.037  0.871  0.033  0.885  0.355  0.105  
Females             
Actinobacteria -0.155  0.423  0.007  0.970  0.055  0.778  
Bacteroidetes 0.037  0.850  -0.077  0.690  -0.177  0.359  
Firmicutes 0.000  0.998  0.102  0.597  0.132  0.495  
Proteobacteria -0.159  0.410  -0.254  0.183  -0.251  0.189  
r Values indicate Spearman’s rank correlation coefficients. 
SDS: standard deviation score 
  
 Table 7. Adjusted correlation between genus of maternal microbiota and newborn 
anthropometrics 
Variables 
Height SDS 
r p value Adjusted r p value 
Females       
Streptococcus -0.371  0.047  -0.413 0.040 
  
Weight SDS 
r p value Adjusted r p value 
Males       
Eggerthella -0.530  0.011  -0.481  0.043 
Collinsella 0.479  0.024  0.356 0.148 
Anaerostipes -0.450  0.036  -0.452 0.060 
Females       
Streptococcus -0.404  0.030  -0.232 0.265 
  
Head circumference SDS 
r p value Adjusted r p value 
Males       
Lachnospiraceae Ruminococcus -0.546  0.009  -0.328 0.183 
Parabacteroides -0.489  0.021  -0.598 0.009 
Lachnobacterium 0.484  0.022  0.392 0.107 
Bacteroides -0.451  0.035  -0.336 0.172 
Eggerthella -0.438  0.042  -0.408 0.093 
Dorea -0.426  0.048  -0.457 0.057 
Coriobacteriaceae unclassified 0.424  0.049  0.297  0.232 
The data with significant p values in non-adjusted correlation are shown in the table. 
r values indicate Spearman’s rank correlation coefficients. 
Adjusted r values indicate Spearman’s partial correlation coefficients with covariates 
including maternal height, pre-pregnancy BMI, gestational weight gain, and delivery 
mode. 
Significant p values (p < 0.05) are shown in bold. 
SDS: standard deviation score 
  
 Table 8. The concentrations of SCFAs (μmol/g) in maternal stool 
Variables 
Total 
(n=51) 
Males 
(n=22) 
Females 
(n=29) 
Acetate 13.2101 (11.402) 11.8935 (13.9822) 13.4124 (10.5469) 
Propionate 8.3711 (4.6422) 8.2957 (5.0118) 8.3711 (4.9085) 
Isobutyrate 0.4764 (0.6748) 0.4787 (0.8834) 0.4619 (0.5699) 
Butyrate 3.485 (2.7268) 3.9757 (3.4219) 3.3759 (2.3978) 
Isovalerate 0.1536 (0.3672) 0.1585 (0.41) 0.1498 (0.3256) 
Valerate 0.2459 (0.5144) 0.2556 (0.481) 0.2459 (0.5854) 
Hexanoate 0.0209 (0.0354) 0.0213 (0.1057) 0.0206 (0.0311) 
Values are presented as median (interquartile range). 
SCFAs: short-chain fatty acids 
  
 Table 9. Correlation between maternal SCFAs in stool and newborn anthropometrics 
Variables 
Height SDS Weight SDS Head circumference SDS 
r p value r p value r p value 
Males             
Acetate -0.006  0.980  -0.276  0.214  0.167  0.459  
Propionate 0.249  0.265  -0.200  0.371  0.023  0.921  
Isobutyrate 0.064  0.778  -0.354  0.106  -0.115  0.611  
Butyrate 0.005  0.982  -0.357  0.102  0.286  0.197  
Isovalerate -0.007  0.975  -0.251  0.261  -0.138  0.540  
Valerate 0.069  0.759  -0.181  0.420  0.045  0.844  
Hexanoate -0.025  0.913  0.040  0.859  0.463  0.030  
Females             
Acetate -0.158  0.413  -0.037  0.849  0.058  0.764  
Propionate -0.099  0.610  -0.083  0.668  -0.019  0.921  
Isobutyrate -0.003  0.987  -0.231  0.229  -0.349  0.064  
Butyrate -0.086  0.657  -0.121  0.531  -0.058  0.764  
Isovalerate -0.038  0.844  -0.127  0.512  -0.265  0.165  
Valerate 0.048  0.804  0.009  0.962  -0.028  0.887  
Hexanoate 0.448  0.015  0.161  0.405  0.052  0.790  
r Values indicate Spearman’s rank correlation coefficients. 
Significant p values (p < 0.05) are shown in bold. 
SCFAs: short-chain fatty acids 
SDS: standard deviation score 
  
 Table 10. Adjusted correlation between maternal SCFAs in stool and newborn 
anthropometrics 
Variables 
Height SDS 
 r p value Adjusted r p value 
Females        
Hexanoate 0.448 0.015 0.377 0.063 
  
Head circumference SDS 
 r p value Adjusted r p value 
Males        
Hexanoate 0.463 0.030 0.373 0.127 
The data with significant p values in non-adjusted correlation are shown in the table. 
r values indicate Spearman’s rank correlation coefficients. 
Adjusted r values indicate Spearman’s partial correlation coefficients with covariates 
including maternal height, pre-pregnancy BMI, gestational weight gain, and delivery 
mode. 
Significant p values (p < 0.05) are shown in bold. 
SCFAs: short-chain fatty acids 
  
 Figure 1. Correlation between maternal gut microbiota and SCFAs in stool in all study 
subjects (n = 51) 
Heatmap shows correlations between maternal gut microbiota related to newborn 
anthropometrics and SCFAs in stool.  
Colour intensity represents magnitude of correlation evaluated using Spearman’s rank 
correlation coefficients. 
Blue colour means negative correlation; Red colour means positive correlation. 
SCFAs: short-chain fatty acids 
OTUs: operational taxonomic units 
* p < 0.05, ** p < 0.01 
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